CN109288884B - Preparation method and application of sunflower extract with soothing and repairing effects - Google Patents
Preparation method and application of sunflower extract with soothing and repairing effects Download PDFInfo
- Publication number
- CN109288884B CN109288884B CN201811541249.8A CN201811541249A CN109288884B CN 109288884 B CN109288884 B CN 109288884B CN 201811541249 A CN201811541249 A CN 201811541249A CN 109288884 B CN109288884 B CN 109288884B
- Authority
- CN
- China
- Prior art keywords
- sunflower
- phase
- extract
- soothing
- repairing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000003222 Helianthus annuus Nutrition 0.000 title claims abstract description 83
- 241000208818 Helianthus Species 0.000 title claims abstract description 82
- 239000000284 extract Substances 0.000 title claims abstract description 57
- 230000000694 effects Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000706 filtrate Substances 0.000 claims abstract description 23
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 22
- 239000002537 cosmetic Substances 0.000 claims abstract description 21
- 239000012528 membrane Substances 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 206010020751 Hypersensitivity Diseases 0.000 claims abstract description 11
- 208000026935 allergic disease Diseases 0.000 claims abstract description 11
- 230000007815 allergy Effects 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 9
- 238000000926 separation method Methods 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 52
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 29
- 239000004310 lactic acid Substances 0.000 claims description 26
- 235000014655 lactic acid Nutrition 0.000 claims description 26
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 108010003272 Hyaluronate lyase Proteins 0.000 claims description 14
- 102000001974 Hyaluronidases Human genes 0.000 claims description 14
- 229960002773 hyaluronidase Drugs 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 239000002884 skin cream Substances 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 229960002504 capsaicin Drugs 0.000 claims description 10
- 235000017663 capsaicin Nutrition 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 239000000919 ceramic Substances 0.000 claims description 7
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 239000008387 emulsifying waxe Substances 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 4
- 229940122393 Hyaluronidase inhibitor Drugs 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 230000003266 anti-allergic effect Effects 0.000 claims description 3
- 229940110456 cocoa butter Drugs 0.000 claims description 3
- 235000019868 cocoa butter Nutrition 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 21
- 238000012360 testing method Methods 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 10
- 229960000583 acetic acid Drugs 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 8
- 208000010668 atopic eczema Diseases 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 230000008439 repair process Effects 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000008591 skin barrier function Effects 0.000 description 6
- 230000000172 allergic effect Effects 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 4
- 206010012442 Dermatitis contact Diseases 0.000 description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 4
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 4
- 229940074393 chlorogenic acid Drugs 0.000 description 4
- 235000001368 chlorogenic acid Nutrition 0.000 description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 4
- 208000010247 contact dermatitis Diseases 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000035618 desquamation Effects 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000742679 Coprosma repens Species 0.000 description 2
- 206010012434 Dermatitis allergic Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 230000009285 allergic inflammation Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- -1 coumarin, phenols Chemical class 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- 241001532704 Azolla Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241001280173 Crassula muscosa Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method and application of a sunflower extract with a soothing and repairing effect. The method comprises the following steps: (1) mixing sunflower discs and sunflower seed cakes according to a weight ratio of 1: 0.01-1, and crushing to obtain sunflower powder; (2) adding a solvent into the sunflower powder, and extracting at the temperature of 60-80 ℃ to obtain an extracting solution; then centrifuging the extracting solution, and collecting filtrate; and concentrating the filtrate after membrane separation to obtain the sunflower extract. The sunflower disc and the sunflower seed cake are reasonably compounded, and then the pure natural extract with the effect of relieving and repairing is prepared through extraction and separation. Therefore, the sunflower extract can be applied to cosmetics or medicines with the functions of relieving allergy and repairing damaged skin.
Description
Technical Field
The invention belongs to the field of natural medicinal chemistry and the technical field of cosmetics, and particularly relates to a preparation method and application of a sunflower extract with a soothing and repairing effect.
Background
Sunflower (Helianthus annuus L.) is one of the important oil crops in China and the earliest edible crops in China, has a history of 5000-6000 years to date, and is widely applied to the fields of pharmaceutical chemicals, food and the like. The oil production is inferior to soybean, the cultivation area is inferior to soybean and rape, the third place is that the sunflower seeds as fruit can be eaten for a long time besides being used for oil pressing, and the sunflower seeds have very good health care function. At present, the extraction of sunflower oil is already realized in industrial production, but byproducts such as sunflower discs, sunflower seed shells, cake and the like are still not utilized sufficiently.
Regarding the utilization of sunflower-related by-products, the main focus is on flower discs, and other reports are less. For example, the biological technology 201020 (2)74-77 of the shinyleaf solomonseal rhizome and the like extracts water-soluble polysaccharide from sunflower discs, and the Chinese patent CN106386873A of the shinyleaf azolla herb and the like uses the sunflower discs as raw materials and obtains the plant-derived bacteriostatic agent for inhibiting the fusarium oxysporum by a water extraction centrifugation method. Guochet et al (Chinese patent CN 108379318A) uses sunflower discs as raw material, and extracts are obtained by centrifuging with water to obtain precipitate, and ultrafiltering and filtering with 0.45um filter membrane to obtain extract for inhibiting xanthine oxidase activity. Jieyong et al (Chinese patent CN 107049883A) use sunflower seed oil to extract oil soluble substances from sunflower seed cake, and the obtained extract has sunscreen and synergistic effects.
Skin allergies are also known as "sensitive" skin. From the medical point of view, skin allergy mainly refers to the abnormal phenomena of skin inflammation, itching and pain, desquamation, allergic dermatitis and the like caused by various stimulations to the skin. Under the derivation of green, environment-friendly, chongshang nature and returning nature concepts, natural plants are more and more widely applied in the field of cosmetics. Researches show that leaves, flowers, flower discs, shells, roots, stem pith and the like of the sunflower can be used as medicines, and have good medicinal value. The main chemical components of the composition comprise terpenoids such as sesquiterpene, diterpene, sesquiterpene lactone, triterpenes, etc., and also comprise sterol, coumarin, phenols, flavonoids, volatile substances, etc. Wherein, the sunflower discs contain chlorogenic acid, terpenes, flavonoids and other active substances which not only have bacteriostatic effect, but also have antioxidant activity. Sunflower seeds contain 21-30% of protein, 28-32% of grease and abundant VE and VB6And carotene, and further contains 12.6% of saccharides, 2.7% of cellulose, and 4.4% of ash, and has high contents of trace elements and various vitamins, and a large amount of effective components remain in the cake after the oil and fat are extracted. Thus, it is possible to provideThe effective components of the sunflower discs and the cakes are fully utilized, and the method has very important significance for further improving the corresponding economic value in the industrial chain. However, no reports related to the anti-allergy aspect after the two are compounded are found at present.
Therefore, it is very necessary to invent a sunflower extract with a soothing and repairing effect.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provide a preparation method of a sunflower extract with a soothing and repairing effect.
The invention also aims to provide the sunflower extract with the effect of relieving and repairing, which is prepared by the method.
Still another object of the present invention is to provide the use of sunflower extract with soothing and repairing action.
The purpose of the invention is realized by the following technical scheme: a preparation method and application of sunflower extract with soothing and repairing effects comprise the following steps:
(1) mixing sunflower discs and sunflower seed cakes according to a weight ratio of 1: 0.01-1, and crushing to obtain sunflower powder;
(2) adding a solvent into the sunflower powder obtained in the step (1), and extracting at the temperature of 60-80 ℃ to obtain an extracting solution; then centrifuging the extracting solution, and collecting filtrate; and concentrating the filtrate after membrane separation to obtain sunflower extract.
The weight ratio of the sunflower discs to the sunflower seed cakes in the step (1) is preferably 1: 0.05 to 1.
The particle size of the sunflower powder in the step (1) is 10-100 meshes; preferably 20 to 80 mesh.
The weight ratio of the sunflower powder to the solvent in the step (2) is 1: 1-30; preferably 1: 5-20.
The solvent in the step (2) is one or a mixture of more than two of water, an alcohol solvent or an ester solvent; preferably one or a mixture of more than two of water, ethanol, ethyl acetate and butanediol; more preferably 50-95% (w/w) ethanol aqueous solution, ethyl acetate, or 50% (w/w) butanediol aqueous solution.
The extraction time in the step (2) is 30-180 minutes; preferably 60 to 180 minutes.
The membrane separation described in step (2) is preferably achieved by: and separating the filtrate by using a ceramic membrane with the aperture of 500 nm-1000 nm and an ultrafiltration membrane with the aperture of 3000 Da-10000 Da in sequence.
The concentration in the step (2) is carried out at 40-80 ℃ and-0.1-0.3 MPa vacuum degree; preferably, the concentration is carried out at 60-80 ℃ and-0.1-0.2 MPa of vacuum degree until the relative density measured at 25 ℃ is 1.05-1.15 (preferably 1.07-1.11).
A sunflower extract prepared by any one of the above methods.
The sunflower extract is applied to the field of cosmetics.
The cosmetics are preferably cosmetics with functions of relieving allergy and repairing damaged skin, and comprise cream emulsions, film powders, jelly, aerosols, pressed powders and the like.
The addition amount of the sunflower extract accounts for 1-50% of the weight of the cosmetic; preferably accounts for 1-5% of the weight of the cosmetic; more preferably 5% by weight of the cosmetic.
The cosmetic also includes a cosmetically acceptable base form.
A soothing and repairing skin cream comprises the following components in percentage by weight:
phase A: 10% of mineral oil; 2% of cocoa butter; vitamin E (vitamin E) 1.3%; 6% of emulsifying wax; 2.8% of glyceryl monostearate; 4% of octadecanol;
phase B: 1-5% of the sunflower extract;
and C phase: 2% of glycerol; 2% of propylene glycol; 0.5 percent of acetic acid monoethanolamide; 0.2 percent of triethanolamine; the deionized water is added to make up to 100 percent.
The emulsifying wax in the phase A is preferably GP2000 emulsifying wax.
The addition amount of the sunflower extract in the B phase is preferably 5% of the weight of the soothing and repairing skin cream.
The phase C also contains a preservative; IS-45 preservative IS preferred.
The addition amount of the preservative is preferably 0.45 percent of the weight of the soothing and repairing skin cream.
The preparation method of the soothing and repairing skin cream comprises the following steps:
(1) mixing the components in the phase A, heating to 70 ℃ to completely melt the components to obtain a phase A mixture;
(2) mixing the components in the phase C, heating to 70 ℃, and uniformly stirring to obtain a phase C mixture;
(3) and adding the phase A mixture into the phase C mixture for emulsification reaction, cooling to 40 ℃ after emulsification is finished, adding the components in the phase B, uniformly stirring, and cooling to room temperature to obtain the soothing and repairing skin cream.
The sunflower extract is applied to the preparation of medicaments for inhibiting hyaluronidase, diminishing inflammation, inhibiting bacteria, improving allergic constitution or resisting allergy.
The allergy includes allergy caused by capsaicin or lactic acid.
The sunflower extract is applied to the preparation of a hyaluronidase inhibitor.
The sunflower extract is used as a hyaluronidase inhibitor.
According to the invention, sunflower resources are fully utilized, namely, effective components of sunflower discs and cakes are utilized, wherein the sunflower discs contain chlorogenic acid, terpenes, flavonoid compounds and other active substances, and the substances not only have an antibacterial effect, but also have antioxidant activity; sunflower seeds contain 21-30% of protein, 28-32% of grease and abundant VE and VB6And carotene, etc. and also contains saccharide 12.6%, cellulose 2.7% and ash 4.4%, and has high content of trace elements and vitamins, so that even the cake after squeezing oil and fat still has a large amount of effective components, sunflower seed protein and chlorogenic acid can be extracted from the cake.
Skin allergy of human body mainly refers to skin diseases such as red and swollen skin, itching, wheal, desquamation and the like caused by contacting human body with certain allergens. Skin disorders caused by allergy include mainly contact dermatitis and cosmetic dermatitis. Contact dermatitis refers to the condition of erythema, edema, itching and pain occurring locally after the skin is contacted with a certain substance, and in severe cases, the skin may have the symptoms of blister, desquamation, etc. Substances capable of causing skin to generate contact dermatitis include jewelry, watch chains, spectacle frames, sandals, chemical fiber cloth, external medicines, chemicals, cosmetics and the like. When the symptoms are found, people who are easy to generate contact dermatitis belong to allergic people in many cases. Cosmetic allergy cosmetic can cause allergic dermatitis symptoms such as red, swollen, hot, painful, blister, etc. Medically, it is best not to use it if it is found to be allergic to certain cosmetic products. But sometimes the hair is not separated in life, such as hair dyeing for middle-aged and old people and light make-up for professional women. The most scientific approach is to improve the allergic constitution fundamentally. Therefore, the mainstream antiallergic method at present is to eliminate or relieve skin inflammation, improve the defense function of the organism and improve the environment and keep away from the allergic source. The sunflower extract disclosed by the invention can effectively repair skin barriers, relieve body damage caused by allergic inflammation and improve the immunity of a body.
Compared with the prior art, the invention has the following advantages and effects:
1. the invention prepares the pure natural extract with the effect of relieving and repairing through extraction and separation after reasonably compounding the sunflower discs and the sunflower seed cakes. The invention utilizes the active substances such as chlorogenic acid, flavonoid and the like with the functions of diminishing inflammation and inhibiting bacteria in the flower disc of the sunflower to play a role in inhibiting the release of inflammatory reaction factors causing allergy; the components such as VE, carotene, polysaccharide and the like with repairing effect in the sunflower seed cake are utilized to relieve and repair the body damage caused by allergic inflammation and improve the immunity of the body.
2. The efficacy experiment proves that the extract has obvious effect of inhibiting hyaluronidase, and the inhibition rate of the extract is increased along with the increase of the application concentration; simultaneously, the stabbing pain caused by the capsaicin and the lactic acid can be relieved; the human body uses the repair skin cream of the invention for 28 days to show that the extract of the invention can obviously repair the barrier function of the damaged skin.
3. The extraction method provided by the invention is simple to operate and short in production period, and the obtained extract can be applied to cosmetics with the functions of relieving allergy and repairing damaged skin (the addition amount is 1% -50%), and has important significance for further improving the corresponding economic value in the industrial chain.
Drawings
FIG. 1 is a graph showing the hyaluronidase inhibition effect of the sunflower extracts of examples 1-4 at different application concentrations.
FIG. 2 is a graph showing the effect of the sunflower extract of examples 1 to 4 in significantly increasing hyaluronidase inhibition with increasing application concentration.
Detailed Description
The present invention will be described in further detail with reference to examples, but the embodiments of the present invention are not limited thereto. Reagents, methods and apparatus used in the present invention are conventional in the art unless otherwise specified; unless otherwise specified, reagents and starting materials for use in the present invention are commercially available.
Example 1
Mixing 1kg commercially available sunflower discs (commercially available sunflower discs are products which are removed of fruits and dried in the sun) and 0.1kg sunflower seed cakes (Shandong Qiaowie food science and technology Co., Ltd., the same below) uniformly, pulverizing into 40 mesh powder, adding 25kg of 50% (w/w) ethanol aqueous solution, extracting at 60 deg.C for 120 min, centrifuging the extractive solution to remove residues, collecting filtrate, separating the filtrate with ceramic membrane with aperture of 500nm and ultrafiltration membrane with aperture of 5000Da respectively, and concentrating at 80 deg.C and vacuum degree of-0.1 MPa to relative density of 1.10(25 deg.C) to obtain sunflower extract.
Example 2
Mixing 1kg of sunflower discs and 0.5kg of sunflower seed cakes uniformly, crushing into 20-mesh powder, adding 30kg of 95% (w/w) ethanol water solution, carrying out reflux extraction at 80 ℃ for 90 minutes, centrifuging the extracting solution to remove dregs, collecting filtrate, separating the filtrate by using a ceramic membrane with the aperture of 800nm and an ultrafiltration membrane with the aperture of 3000Da respectively, and concentrating the filtrate at the temperature of 60 ℃ and the vacuum degree of-0.2 MPa until the relative density is 1.07(25 ℃) to obtain the sunflower extract.
Example 3
Mixing 100g of sunflower discs and 5g of sunflower seed cakes uniformly, crushing into 80-mesh powder, adding 500ml of ethyl acetate, extracting at 70 ℃ for 180 minutes, centrifuging the extracting solution to remove dregs, collecting filtrate, separating the filtrate by using a ceramic membrane with the pore diameter of 1000nm and an ultrafiltration membrane with the pore diameter of 10000Da respectively, and concentrating the filtrate at the temperature of 80 ℃ and the vacuum degree of-0.1 MPa until the relative density is 1.11(25 ℃), thus obtaining the sunflower extract.
Example 4
Mixing 1kg of sunflower discs and 1kg of sunflower seed cakes uniformly, crushing into 60-mesh powder, adding 40kg of 50% (w/w) butanediol aqueous solution, extracting at 60 ℃ for 60 minutes, centrifuging the extracting solution to remove dregs, collecting filtrate, separating the filtrate by using a ceramic membrane with the aperture of 500nm and an ultrafiltration membrane with the aperture of 5000Da respectively, and concentrating at the temperature of 75 ℃ and the vacuum degree of-0.1 MPa until the relative density is 1.08(25 ℃), thus obtaining the sunflower extract.
Comparative example 1
The same as example 3, except that 100g of sunflower discs and 110g of sunflower seed meal were mixed and then subjected to the following operations:
mixing 100g of sunflower discs and 110g of sunflower seed cakes uniformly, crushing into 80-mesh powder, adding 1000ml of ethyl acetate, extracting at 70 ℃ for 180 minutes, centrifuging the extracting solution to remove dregs, collecting filtrate, separating the filtrate by using a ceramic membrane with the pore diameter of 1000nm and an ultrafiltration membrane with the pore diameter of 10000Da respectively, and concentrating the filtrate at the temperature of 80 ℃ and the vacuum degree of-0.1 MPa until the relative density is 1.11(25 ℃), thus obtaining the sunflower extract.
Comparative example 2
The difference from example 2 is that the extraction centrifugation is followed by concentration:
mixing 1kg of sunflower discs and 0.5kg of sunflower seed cakes uniformly, crushing to 20-mesh powder, adding 30kg of 95% (w/w) ethanol water solution, carrying out reflux extraction at 80 ℃ for 90 minutes, centrifuging the extracting solution to remove dregs, collecting filtrate, and concentrating the filtrate at the temperature of 60 ℃ and the vacuum degree of-0.2 MPa until the relative density is 1.07(25 ℃), thus obtaining the sunflower extract.
Example 5
A soothing and repairing skin cream comprises the following components in percentage by weight:
phase A: 10% of mineral oil; 2% of cocoa butter; vitamin E (vitamin E) 1.3%; 6% of GP2000 emulsifying wax; 2.8% of glyceryl monostearate; 4% of octadecanol;
phase B: example 2 preparation of sunflower extract 5%;
and C phase: 2% of glycerol; 2% of propylene glycol; 0.5 percent of acetic acid monoethanolamide; 0.2 percent of triethanolamine; IS-45 preservative 0.45%; the deionized water is added to make up to 100 percent.
The preparation method comprises the following steps:
1. heating the phase A oil-soluble component to 70 ℃ to completely melt the phase A oil-soluble component to obtain a material 1 for later use;
2. heating the other C-phase water-soluble component (except other components) and water to 70 ℃, and uniformly stirring to obtain a material 2 for later use;
3. and (3) adding the materials 1 and 2 into an emulsion reactor simultaneously for emulsion reaction, cooling to below 40 ℃ after the emulsion reaction is finished, adding the phase B, uniformly stirring, and cooling.
To further illustrate the specific effects of the present invention, the following experiments were performed to verify the effects of the present invention.
Effect example 1
Hyaluronidase inhibition assay:
1. reagent and apparatus
Sample preparation: the sunflower extract prepared in examples 1 to 4 was diluted with purified water to a concentration of 1%, 3%, 5% (W/W).
Hyaluronidase (I): the concentration is 500U/ml, the solution is used as it is, and the acetic acid buffer solution is used as the solvent.
Sodium hyaluronate (120 ppm molecular weight): 0.5mg/ml, one-time preparation and multiple use, and acetic acid buffer solution is used as a solvent.
Buffer: 4.8ml of solution A (0.2mol/L acetic acid: 11.55ml glacial acetic acid in 1L distilled water) and 45.2ml of solution B (0.2mol/L sodium acetate: 16.4g anhydrous sodium acetate in 1L distilled water) were mixed and diluted to 100ml to prepare an acetic acid buffer solution having a pH of 5.6.
Acetylacetone solution: 50ml of a 1.0mol/L sodium carbonate solution and 3.5ml of acetylacetone are mixed homogeneously (ready for use).
P-DAB color developing agent: 0.8g of p-dimethylaminobenzaldehyde is dissolved in 15ml of concentrated hydrochloric acid (12mol/L) and 15ml of absolute ethanol and mixed uniformly.
Calcium chloride solution (CaCl)2Solution): 2.5 mol/L.
Sodium hydroxide solution (NaOH solution): 5 mol/L.
2. Procedure of experiment
A25 ml cuvette was taken and operated according to the procedure in Table 1, in parallel for 3 times.
TABLE 1 Hyaluronidase inhibition assay specific procedures
3. Calculation and results
Hyaluronidase inhibition (%) - (C-D) - (A-B) ]/(C-D) × 100%
In the formula:
OD value of a — (hyaluronidase + sample + sodium hyaluronate) test sample solution;
OD value of blank sample B (acetic acid buffer solution + sample + acetic acid buffer solution);
OD value of C- (hyaluronidase + distilled water + sodium hyaluronate) control solution;
d- (acetate buffer + distilled water + acetate buffer) control blank OD value.
The results are shown in Table 2 and FIGS. 1 to 2.
TABLE 2 Hyaluronidase inhibition
| Application concentration | Example 1 | Example 2 | Example 3 | Example 4 | Comparative example 1 | Comparative example 2 |
| Sample concentration (1%) | 45.0%±2.0 | 47.5%±1.8 | 56.1%±1.5 | 49.5%±2.2 | 13.1%±0.9 | 8.3%±4.2 |
| Sample concentration (3%) | 74.1%±1.5 | 81.4%±1.3 | 85.6%±2.4 | 70.1%±2.4 | 26.0%±1.2 | 10.6%±7.8 |
| Sample concentration (5%) | 91.2%±2.6 | 95.0%±2.3 | 96.3%±3.1 | 90.4%±1.6 | 36.5%±2.7 | 12.4%±6.8 |
As can be seen from Table 2, examples 1 to 4 of the present invention all had a good hyaluronidase inhibitory effect, and the inhibitory rate tended to increase with the increase in the application concentration. The extracts of examples 1-4 all achieved over 90% inhibition at 5% application concentration.
In comparative examples 1 and 2, the inhibition rate increased with increasing application concentration, but the effect was inferior to examples 1 to 4. In particular, the extract obtained in comparative example 2 was agglomerated and difficult to disperse and dissolve when diluted with pure water to the concentration for use in the experiment, which was also a cause of low hyaluronidase inhibition and large parallel group deviation.
Effect example 2 relief of capsaicin and lactic acid stinging
First, reduction of lactic acid stinging test
Screening lactic acid stabbing pain population: at room temperature, 20. mu.L of 10% (w/w) aqueous lactic acid solution was applied to the nasolabial sulcus, and the subjective symptoms of the subjects were asked at 0, 3, 5 and 10min, respectively, and scored by 4 points (0 point was no stinging sensation, 1 point was mild stinging, 2 point was moderate stinging, 3 point was severe stinging), and the lactic acid sting reaction was positive for 3 total points and 3 points or more. And selecting the lactic acid stabbing positive reaction as a qualified subject to be tested in the next step.
The experimental process comprises the following steps:
randomly dividing the 16 people with lactic acid stabbing positive reaction into two groups (20-50 years old, half of each male and female):
negative group: applying 30 μ L of pure water to nasolabial sulcus, and applying 20 μ L of 10% (w/w) lactic acid aqueous solution to the same part after 5 min.
Test groups: 30. mu.L of the sample solution (sunflower extract prepared in examples 1 to 4) was applied to the nasolabial folds, and 20. mu.L of a 10% (w/w) aqueous solution of lactic acid was applied to the same site after 5 min.
The lactic acid solution was applied to the nasolabial fold and scored as described above, and analyzed using SPSS 19.0 statistical software, with the results shown in table 3.
TABLE 3 reduction of lactic acid stinging results
| Time | Test group | Negative group | Two sets of phase contrast (P value) |
| Example 1 | 5.3±0.7 | 7.5±0.9 | <0.05 |
| Example 2 | 4.8±1.2 | 7.1±1.1 | <0.05 |
| Example 3 | 3.6±0.6 | 7.6±1.5 | <0.05 |
| Example 4 | 4.9±1.3 | 8.6±0.7 | <0.05 |
As can be seen from table 3, the sample liquid was effective in relieving the stinging sensation caused by lactic acid.
Experiment for reducing capsaicin stabbing pain
Capsaicin, when applied to the skin, causes dilation of the microvasculature, which results in redness and warmth of the skin, accelerates the local metabolic rate, and also stimulates the pain nerves, causing the person to feel stinging.
The experimental process comprises the following steps: adding 500mg capsaicin into 10ml 70% (w/w) ethanol, and shaking to dissolve to obtain 5% capsaicin solution. The rest of the procedures were the same as the lactic acid stinging test described above, and the results are shown in Table 4.
TABLE 4 reduction of capsaicin sting results
| Time | Test group | Negative group | Two sets of phase contrast (P value) |
| Example 1 | 8.2±0.7 | 10.5±1.4 | <0.05 |
| Example 2 | 7.5±1.2 | 10.3±1.7 | <0.05 |
| Example 3 | 7.9±1.6 | 11.4±0.9 | <0.05 |
| Example 4 | 6.3±1.1 | 10.6±1.3 | <0.05 |
The results demonstrate that the sample fluid is effective in alleviating the stinging sensation caused by capsaicin.
Effect example 3 skin repair experiment
The experimental principle is as follows:
when the skin barrier is damaged, lactic acid enters the skin, stimulating nerves, and thus causing a tingling sensation. When the skin barrier is effectively repaired, the chance of lactic acid passing through the skin barrier is reduced, thereby alleviating the stinging sensation. The method is simple, convenient, effective and high in repeatability, and is widely applied to clinical evaluation of skin repair detection and experimental research.
Screening lactic acid stabbing pain population:
the difference between the lactic acid and the lactic acid sting reducing test is that the lactic acid is smeared on two cheeks of the face. Selecting lactic acid positive sting reaction subjects for further testing.
The experimental process comprises the following steps:
negative group: blank placebo-the ingredients and preparation were the same as example 5 except that no sunflower extract was included.
Test groups: sunflower extract prepared according to example 5.
Test samples: the subjects in the test group and the negative group were asked to be positive for lactic acid stinging, and the cycle was 28 days. Subjects were asked to apply the test group product to one face and the negative group product to the other face (both groups of products are indicated by a code, and the user and the test staff were double blind controlled), once in the morning and once in the evening.
The test process comprises the following steps: the lactic acid stinging tests were performed on the first day (D0), fourteenth day (D14) and twenty-eighth day (D28) of the enrollment tests, scored as described above and analyzed using SPSS 19.0 statistical software, with the results shown in table 5.
Table 5 skin barrier repair experimental results
| Time | Test group | Negative group | Two sets of phase contrast (P value) |
| D0 | 8.2±0.5 | 8.3±0.6 | >0.05 |
| D14 | 5.0±0.8 | 7.4±0.3 | <0.05 |
| D28 | 3.1±1.1 | 6.3±0.5 | <0.05 |
The results show that the lactic acid stinging scores of the test groups have statistical significance (P < 0.05) compared with the time points of the negative groups D14 and D28, and that the products prepared from the sunflower extract have the effects of repairing skin barriers and resisting allergy.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (8)
1. A preparation method of a sunflower extract with a soothing and repairing effect is characterized by comprising the following steps:
(1) mixing sunflower discs and sunflower seed cakes according to a weight ratio of 1: 0.05-1, and crushing to obtain sunflower powder;
(2) adding a solvent into the sunflower powder obtained in the step (1), and extracting at the temperature of 60-80 ℃ to obtain an extracting solution; then centrifuging the extracting solution, and collecting filtrate; concentrating the filtrate after membrane separation to obtain sunflower extract;
the membrane separation in the step (2) is realized by the following steps: separating the filtrate by using a ceramic membrane with the aperture of 500 nm-1000 nm and an ultrafiltration membrane with the aperture of 3000 Da-10000 Da in sequence;
the weight ratio of the sunflower powder to the solvent in the step (2) is 1: 5-20;
the solvent in the step (2) is one or two of water, ethanol, ethyl acetate and butanediol;
the concentration in the step (2) is carried out at 60-80 ℃ and-0.1-0.2 MPa of vacuum degree, and the concentration is carried out until the relative density measured at 25 ℃ is 1.05-1.15.
2. The method for preparing sunflower extract with soothing and repairing effects as claimed in claim 1, wherein:
the particle size of the sunflower powder in the step (1) is 10-100 meshes;
the extraction time in the step (2) is 30-180 minutes.
3. A sunflower extract characterized by: prepared by the method of any one of claims 1 to 2.
4. Use of the sunflower extract according to claim 3 in the cosmetic field.
5. Use of sunflower extract according to claim 4 in the cosmetic field, characterized in that:
the addition amount of the sunflower extract accounts for 1-50% of the weight of the cosmetic;
the cosmetics are cream emulsion, film powder, jelly, aerosol or pressed powder cosmetics.
6. A soothing and repairing skin cream is characterized in that: comprises the following components in percentage by weight:
phase A: 10% of mineral oil; 2% of cocoa butter; 1.3 percent of vitamin E; 6% of emulsifying wax; 2.8% of glyceryl monostearate; 4% of octadecanol;
phase B: 1-5% of the sunflower extract of claim 3;
and C phase: 2% of glycerol; 2% of propylene glycol; 0.5 percent of acetic acid monoethanolamide; 0.2 percent of triethanolamine; supplementing deionized water to 100%;
the phase C also contains a preservative;
the addition amount of the preservative accounts for 0.45 percent of the weight of the soothing and repairing skin cream;
the preparation method of the soothing and repairing skin cream comprises the following steps:
(1) mixing the components in the phase A, heating to 70 ℃ to completely melt the components to obtain a phase A mixture;
(2) mixing the components in the phase C, heating to 70 ℃, and uniformly stirring to obtain a phase C mixture;
(3) and adding the phase A mixture into the phase C mixture for emulsification reaction, cooling to 40 ℃ after emulsification is finished, adding the components in the phase B, uniformly stirring, and cooling to room temperature to obtain the soothing and repairing skin cream.
7. Use of sunflower extract according to claim 3 for the preparation of a medicament for inhibiting hyaluronidase or antiallergic, characterized in that:
the allergy is caused by capsaicin or lactic acid.
8. Use of the sunflower extract of claim 3 for the preparation of a hyaluronidase inhibitor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811541249.8A CN109288884B (en) | 2018-12-17 | 2018-12-17 | Preparation method and application of sunflower extract with soothing and repairing effects |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811541249.8A CN109288884B (en) | 2018-12-17 | 2018-12-17 | Preparation method and application of sunflower extract with soothing and repairing effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN109288884A CN109288884A (en) | 2019-02-01 |
| CN109288884B true CN109288884B (en) | 2021-09-07 |
Family
ID=65142493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811541249.8A Active CN109288884B (en) | 2018-12-17 | 2018-12-17 | Preparation method and application of sunflower extract with soothing and repairing effects |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109288884B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112773743B (en) * | 2021-01-28 | 2022-08-26 | 通化承诚药业有限公司 | Sunflower disc preparation and preparation method and application thereof |
| CN113234528A (en) * | 2021-04-29 | 2021-08-10 | 张世华 | Preparation method of sunflower disc extract |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991011169A1 (en) * | 1990-01-24 | 1991-08-08 | Claude Bonne | Cosmetic compositions containing an essence of sunflower oil cake (helianthus annuus) |
| FR2844200A1 (en) * | 2002-09-10 | 2004-03-12 | Vincience | Cosmetic and/or pharmaceutical compositions for treating keratin substrates, e.g. skin or hair, containing dephenolated sunflower protein hydrolyzates having e.g. moisturizing, antioxidant and antiaging effects |
| CN102086235A (en) * | 2010-11-27 | 2011-06-08 | 齐齐哈尔大学 | Three sunflower seed polysaccharides and method for extracting, isolating and purifying sunflower seed water-soluble polysaccharide |
| CN103641717A (en) * | 2013-12-18 | 2014-03-19 | 中国农业科学院兰州畜牧与兽药研究所 | Method for extracting and separating chlorogenic acid from flower disk of sunflower in florescence |
| CN105920067A (en) * | 2016-05-06 | 2016-09-07 | 洮南市金塔生物科技有限公司 | Sunflower calathide extract containing polysaccharide, flavonoid and alkaloid and preparation method of sunflower calathide extract |
| CN107049883A (en) * | 2017-06-20 | 2017-08-18 | 广东盛美化妆品有限公司 | A kind of preparation method of sunflower seed extract and its application in cosmetics |
| CN107334674A (en) * | 2017-07-10 | 2017-11-10 | 玉溪师范学院 | A kind of floral disc of sunflower white cotton pad extract and its application |
| CN107603743A (en) * | 2017-09-22 | 2018-01-19 | 广州聚禅现代农业研究院有限公司 | A kind of extracting method of sunflower seed dregs biowax and application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104027293B (en) * | 2014-06-27 | 2018-07-13 | 高宝化妆品(中国)有限公司 | A kind of skin-lightening cosmetic and preparation method thereof |
| CN106508971B (en) * | 2016-08-31 | 2018-12-14 | 甘肃敬业农业科技有限公司 | Floral disc of sunflower bacteriostatic agent, preparation method and its application in prevention and treatment dry rot of potato |
| CN108567594A (en) * | 2017-03-14 | 2018-09-25 | 玫琳凯有限公司 | Cosmetic composition and method |
| CN108354956A (en) * | 2018-03-08 | 2018-08-03 | 吉林大学 | Sunflower disk powder and its active ingredient are preparing the application in repairing wounded hepatocytes drug |
-
2018
- 2018-12-17 CN CN201811541249.8A patent/CN109288884B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991011169A1 (en) * | 1990-01-24 | 1991-08-08 | Claude Bonne | Cosmetic compositions containing an essence of sunflower oil cake (helianthus annuus) |
| FR2844200A1 (en) * | 2002-09-10 | 2004-03-12 | Vincience | Cosmetic and/or pharmaceutical compositions for treating keratin substrates, e.g. skin or hair, containing dephenolated sunflower protein hydrolyzates having e.g. moisturizing, antioxidant and antiaging effects |
| CN102086235A (en) * | 2010-11-27 | 2011-06-08 | 齐齐哈尔大学 | Three sunflower seed polysaccharides and method for extracting, isolating and purifying sunflower seed water-soluble polysaccharide |
| CN103641717A (en) * | 2013-12-18 | 2014-03-19 | 中国农业科学院兰州畜牧与兽药研究所 | Method for extracting and separating chlorogenic acid from flower disk of sunflower in florescence |
| CN105920067A (en) * | 2016-05-06 | 2016-09-07 | 洮南市金塔生物科技有限公司 | Sunflower calathide extract containing polysaccharide, flavonoid and alkaloid and preparation method of sunflower calathide extract |
| CN107049883A (en) * | 2017-06-20 | 2017-08-18 | 广东盛美化妆品有限公司 | A kind of preparation method of sunflower seed extract and its application in cosmetics |
| CN107334674A (en) * | 2017-07-10 | 2017-11-10 | 玉溪师范学院 | A kind of floral disc of sunflower white cotton pad extract and its application |
| CN107603743A (en) * | 2017-09-22 | 2018-01-19 | 广州聚禅现代农业研究院有限公司 | A kind of extracting method of sunflower seed dregs biowax and application |
Non-Patent Citations (2)
| Title |
|---|
| 向日葵副产物资源的综合利用;刘清,等;《农业工程学报》;20111231;第27卷;第336-340页 * |
| 葵花籽活性成分及生理功能研究进展;胡超,等;《中国食物与营养》;20171031;第23卷(第10期);对比文件2第59页右栏第3段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109288884A (en) | 2019-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106333885B (en) | One Plant Extracts and eye essence | |
| CN107569674B (en) | Anti-allergy relieving composition and application thereof | |
| KR100982883B1 (en) | Cosmetic composition comprising a mixed extract and a method for preparing the same | |
| CN107714531B (en) | Anti-allergy relieving composition and application thereof | |
| KR102330465B1 (en) | Composition for skin comprising pine bark extract reducing edema, cellulite, breaking down body fat, promoting blood circulation and skin cream comprising thereof | |
| JP2946183B2 (en) | Perilla extract having TNF production inhibitory action | |
| CN109288884B (en) | Preparation method and application of sunflower extract with soothing and repairing effects | |
| KR20120053390A (en) | The cosmetics to have an atopic dermatitis improvement efficacy making method besides | |
| CN110141538A (en) | Hyaluronic acid decomposing inhibitor comprising Rosmarinus officinalis extract and retinol acetate | |
| CN109568156A (en) | A kind of antiallergy toner and its preparation method and application containing trollflower | |
| CN111643610A (en) | Plant composite liquid and preparation method and application thereof | |
| KR101822092B1 (en) | Cosmetic composition for preventing thermal skin aging containing aloe vera leaves complex extract | |
| KR101482194B1 (en) | Anti-oxidant, anti-inflammatory and anti-allergic composition for cosmetics comprising vegetable ingredients | |
| EP2985030B1 (en) | Eye-refreshing agent to eliminate and alleviate eye fatigue and discomfort | |
| CN102091003B (en) | External skin agent for relieving skin irritation | |
| KR100712249B1 (en) | Cosmetic composition for improving oily skin containing herbal extract and method for producing same | |
| CN108703899B (en) | Skin-care massage essential oil | |
| EP3299026B1 (en) | Extracts made from seeds of aframomum species and their use | |
| KR102581166B1 (en) | Cosmetic composition comprising Dendropanax morbifera Extract for improving acne skin | |
| Bal et al. | Preparation and evalauation of novel Aloe vera gel beads | |
| JP4105498B2 (en) | A composition effective for prevention and alleviation of symptoms of atopic disease | |
| CN114129488A (en) | Application of choerospondias axillaris peel extract in preparation of anti-allergic cosmetics | |
| Chirila et al. | Physico-chemical characterisation of sea buckthorn extracts for cosmetic use | |
| CN107823339A (en) | A kind of Chinese medicine composition and its preparation method and application | |
| JP6391879B1 (en) | Beauty method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |

